[Human natural killer activity in selected test systems and tissue compartments: natural killer cell modulation by biological response modifiers]. 1988

G Klappacher
Institut für Angewandte und Experimentelle Onkologie, Universität Wien.

In order to evaluate the effect of biological response modifiers on NK- and NK-like activity, interferons were tested in the single cell cytotoxicity assay (SCCA) with various effector/target combinations. alpha Interferon (IFN-alpha) significantly augmented the cytolysis of K 562 in vitro by non-adherent peripheral blood lymphocytes of normal donors without any influence on the binding capacity. Similarly, in vivo, the intraperitoneal administration of gamma Interferon (IFN-gamma) to patients with ovarian carcinomas resulted in a significant increase in the autologous cytotoxicity in the ascitic compartment. Nevertheless the autologous total killer activity was not improved owing to the countercurrent trend of the conjugate formation. Moreover, we detected a discrepancy in the development of the autologous and allogenic parameters as a result of the strong effects of the peritumorally administered IFN on the effusion tumour cells. In order to investigate the role of epidermal NK-like activity in immunosurveillance we tested epidermal cells as effectors against K 562 and the long-term cultured melanoma cell line RIMA. The SCCA detected the ability of conjugate formation without any cytotoxicity, augmentable significantly and in a dose-related manner by IFN-gamma, as the only one of ten tested biological response modifiers.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

G Klappacher
January 1991, Immunopharmacology and immunotoxicology,
G Klappacher
February 1982, Journal of clinical & laboratory immunology,
G Klappacher
November 1983, Clinical and experimental immunology,
G Klappacher
August 2010, Current opinion in microbiology,
G Klappacher
April 1981, Rinsho byori. The Japanese journal of clinical pathology,
G Klappacher
February 1985, Journal of reproductive immunology,
G Klappacher
January 2020, Frontiers in immunology,
Copied contents to your clipboard!